| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT05663866 Premedication to Reduce Amivantamab Associated Infusion Related Reactions |
date change Completion pushed: 2026-07-30 -> 2027-03-31 |
| 2026-06-03 | NCT07101640 PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With… |
date change Primary completion pushed: 2026-12-31 -> 2028-03-01 |
| 2026-06-03 | NCT07101640 PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With… |
date change Completion pushed: 2028-05-31 -> 2028-06-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07101445 | Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the… | Multiple Myeloma | Recruiting |
| NCT07532993 | Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal… | Allergic Rhinitis (AR) | Not Yet Recruiting |
| Phase 3 | |||
| NCT07320625 | Efficacy of Montelukast on STEMl Patients | Myocardial Infarction (MI) | Recruiting |
| Phase 2/3 | |||
| NCT06113640 | Montelukast in Parkinson Disease | Parkinson Disease | Recruiting |
| Phase 2 | |||
| NCT06356571 | A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and… | Plasma Cell Myeloma Refractory | Recruiting |
| NCT05896228 | Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With… | Refractory Multiple Myeloma | Recruiting |
| NCT07537868 | Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute… | Acute Myocardial Infarction (AMI) | Recruiting |
| NCT05922761 | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) | Bronchiolitis Obliterans Syndrome | Recruiting |
| NCT05704049 | A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and… | Relapsed/Refractory Multiple Myeloma | Active, Not Recruiting |
| NCT04268498 | A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With… | Multiple Myeloma | Active, Not Recruiting |
| NCT05663866 | Premedication to Reduce Amivantamab Associated Infusion Related Reactions | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07101640 | PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With… | Bronchopulmonary Dysplasia (BPD) | Recruiting |
| Early Phase 1 | |||
| NCT04572256 | MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate… | ACL Injury | Recruiting |
| NCT07409714 | SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in… | Type 2 Diabetes | Not Yet Recruiting |